Integrated, coordinated care

Oshi Health surrounds your patients with a team of GI-specialized clinicians, including registered dietitians, GI behavioral health providers, social workers, health coaches, and more to supplement your existing care and help your patients find relief.

Evidence-based care model

Oshi takes pride in our approach to clinical rigor. Our clinicians all bring prior experience in gastroenterology, and undergo an intensive onboarding process before seeing patients. Our clinical care follows societal guidelines from the ACG/AGA/AASLD/ROME and the most updated clinical evidence, supported by advanced data analytics and purpose-built technology to achieve symptom control and disease remission.

We’re seeking high-quality local GI partners

When our members need procedures, we coordinate care with high-quality local GI partners. Let’s talk about how a partnership can work for your practice.

Become An Oshi Health Clinical Partner

Outcomes

98%

patient satisfaction

91%

achieve symptom control in 4 months or less

Conditions we treat

Autoimmune & Inflammatory

Inflammatory Bowel Disease (IBD) – Crohn’s Disease & Ulcerative Colitis
Celiac Disease
Eosinophilic Esophagitis (EOE)
Eosinophilic Gastritis
Microscopic Colitis
Collagenous Colitis
Lymphocytic Colitis
Gastritis
Chronic Pancreatitis

Motility & Gut-Brain Disorders

Irritable bowel syndrome (IBS)
Functional dyspepsia
Functional dysphagia
Gastroparesis
Cyclic vomiting syndrome
Cannabinoid hyperemesis syndrome
Rumination syndrome
Pelvic floor dysfunction
Defecation disorder
Fecal incontinence (Encopresi)s

Undiagnosed Conditions & Symptoms

Dietary Intolerances
Gluten Sensitivity
Fructose, Lactose, Sucrose Intolerance
Constipation
Diarrhea
Gas & Bloating
Abdominal pain & Dyspepsia
Blood in Stool
Iron Deficiency Anemia
Vitamin deficiencies

Structural Disorders

Hemorrhoids
Diverticular disease
Gallbladder & Biliary Disease
Hiatal Hernia
Pancreatic Conditions
Peptic Ulcer Disease
Rectal prolapse

Esophageal

GERD
Reflux & Heartburn
Barrett’s Esophagus
Achalasia & Esophageal Motility Disorders
Dysphagia (Difficulty Swallowing)
Odynophagia (Pain with Swallowing)

Liver

Nonalcoholic Fatty Liver Disease
Nonalcoholic Steotohepatitis
Hepatitis
Drug-Induced Liver Injury
Cirrhosis

Infections

Small Intestinal Bacterial Overgrowth
Helicobacter Pylori
Bacterial, Viral, Parasitic, Fungal Infections
Viral Hepatitis

Screenings

Colon Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer

Others

Management of Total Parenteral
Nutrition (TPN) and IV Fluids

Medical advisors

John Allen, M.D.,
M.B.A., AGAF

Former Chief Clinical Officer
University of Michigan Medical Group
Former President & Chairman
American Gastroenterology Association (AGA)

Gil Y. Melmed MD, MS

Co-Director, Inflammatory Bowel Disease Center
Director, Clinical Research, Inflammatory Bowel and Immunobiology Research Institute
Professor of Medicine
Cedars-Sinai Medical Center

Evidence behind the Oshi Health care model

Many patients continue using proton pump inhibitors after negative results from tests for reflux disease

Feb. 22, 2012
Gawron, Rothe, Fought, Fareeduddin, Toto, Boris, Kahrilas, Pandolfino

The quality of care for gastroesophageal reflux disease

Dec. 27, 2016
Yadlapati, Dakhoul, Pandolfino, Keswani

Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial

Feb. 21, 2013
Singh, Lee, Gupta, Gaddam, Smith, Wani, Sullivan, Rastogi, Bansal, Donnelly, Sharma

Lifestyle intervention in gastroesophageal reflux disease

Feb. 14, 2016
Ness-Jensen, Hveem, El-Serag, Lagergren

Variation in care for patients with irritable bowel syndrome in the United States

April 26, 2016
Lacy, Patel, Guérin , Dea, Scopel, Alaghband, Wu, Mody

Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial

Oct. 31, 2017
Colombel, Panaccione, Bossuyt, Lukas, Baert, Vaňásek, Danalioglu, Novacek, Armuzzi, Hébuterne, Travis, Danese, Reinisch, Sandborn, Rutgeerts, Hommes, Schreiber, Neimark, Huang, Zhou, Mendez, Petersson, Wallace, Robinson, Thakkar, D'Haens

E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘constant-care’ approach

Nov. 11, 2010
Elkjaer, Shuhaibar, Burisch, Bailey, Scherfig, Laugesen, Avnstrøm, Langholz, O'Morain, Lynge, Munkholm"

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial

July 14, 2017
de Jong, van der Meulen-de Jong, Romberg-Camps, Becx, Maljaars, Cilissen